MedTrace Logo

A Pilot Study of Shockwave Therapy in HSP

NCT05411627 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-02-08

No results posted yet for this study

Summary

This is a pilot study of the efficacy, safety, and tolerability of shockwave therapy for the treatment of spasticity in Hereditary Spastic Paraplegia.

Conditions

  • Hereditary Spastic Paraplegia

Interventions

DEVICE

Shockwave Therapy

Participants will receive shockwave therapy once per week for three weeks.

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Spaulding Rehabilitation Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-10-15
Completion
2023-12-15
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05411627 on ClinicalTrials.gov